These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25156675)

  • 1. Antiviral therapy for human rabies.
    Appolinario CM; Jackson AC
    Antivir Ther; 2015; 20(1):1-10. PubMed ID: 25156675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-evaluating the effect of Favipiravir treatment on rabies virus infection.
    Banyard AC; Mansfield KL; Wu G; Selden D; Thorne L; Birch C; Koraka P; Osterhaus ADME; Fooks AR
    Vaccine; 2019 Aug; 37(33):4686-4693. PubMed ID: 29132993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reevaluation of the efficacy of favipiravir against rabies virus using in vivo imaging analysis.
    Yamada K; Noguchi K; Kimitsuki K; Kaimori R; Saito N; Komeno T; Nakajima N; Furuta Y; Nishizono A
    Antiviral Res; 2019 Dec; 172():104641. PubMed ID: 31672666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applying the Milwaukee protocol to treat canine rabies in Equatorial Guinea.
    Rubin J; David D; Willoughby RE; Rupprecht CE; Garcia C; Guarda DC; Zohar Z; Stamler A
    Scand J Infect Dis; 2009; 41(5):372-5. PubMed ID: 19263274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy of rabies-infected mice with inhibitors of pro-inflammatory host response, antiviral compounds and human rabies immunoglobulin.
    Marosi A; Dufkova L; Forró B; Felde O; Erdélyi K; Širmarová J; Palus M; Hönig V; Salát J; Tikos R; Gyuranecz M; Růžek D; Martina B; Koraka P; Osterhaus ADME; Bakonyi T
    Vaccine; 2019 Aug; 37(33):4724-4735. PubMed ID: 29805091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of combined drugs therapy on the course of clinical rabies infection in a murine model.
    Smreczak M; Orłowska A; Marzec A; Trębas P; Kycko A; Reichert M; Koraka P; Osterhaus ADME; Żmudziński JF
    Vaccine; 2019 Aug; 37(33):4701-4709. PubMed ID: 29650384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy of rabies encephalitis.
    Jackson AC
    Biomedica; 2009 Jun; 29(2):169-76. PubMed ID: 20128341
    [No Abstract]   [Full Text] [Related]  

  • 8. Trying to treat the untreatable: experimental approaches to clear rabies virus infection from the CNS.
    Smith SP; Wu G; Fooks AR; Ma J; Banyard AC
    J Gen Virol; 2019 Aug; 100(8):1171-1186. PubMed ID: 31237530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human rabies therapy: lessons learned from experimental studies in mouse models.
    Jackson AC; Scott CA; Owen J; Weli SC; Rossiter JP
    Dev Biol (Basel); 2008; 131():377-85. PubMed ID: 18634499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis.
    Yamada K; Noguchi K; Komeno T; Furuta Y; Nishizono A
    J Infect Dis; 2016 Apr; 213(8):1253-61. PubMed ID: 26655300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of future rabies biologics and antiviral drugs.
    Smith TG; Wu X; Franka R; Rupprecht CE
    Adv Virus Res; 2011; 79():345-63. PubMed ID: 21601054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and future approaches to the therapy of human rabies.
    Jackson AC
    Antiviral Res; 2013 Jul; 99(1):61-7. PubMed ID: 23369672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of rabies virus multiplication by siRNA delivered through adenoviral vector in vitro in BHK-21 cells and in vivo in mice.
    Sonwane AA; Dahiya SS; Saini M; Chaturvedi VK; Singh RP; Gupta PK
    Res Vet Sci; 2012 Aug; 93(1):498-503. PubMed ID: 21767857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of rabies in humans.
    Jackson AC; Warrell MJ; Rupprecht CE; Ertl HC; Dietzschold B; O'Reilly M; Leach RP; Fu ZF; Wunner WH; Bleck TP; Wilde H
    Clin Infect Dis; 2003 Jan; 36(1):60-3. PubMed ID: 12491203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mannitol treatment is not effective in therapy of rabies virus infection in mice.
    Dufkova L; Sirmarova J; Salat J; Honig V; Palus M; Ruzek D; Fooks AR; Mansfield KL; Tordo N; Jochmans D; Neyts J; Martina B; Koraka P; Osterhaus ADME;
    Vaccine; 2019 Aug; 37(33):4710-4714. PubMed ID: 29274698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sufficient virus-neutralizing antibody in the central nerve system improves the survival of rabid rats.
    Liao PH; Yang HH; Chou PT; Wang MH; Chu PC; Liu HL; Chen LK
    J Biomed Sci; 2012 Jun; 19(1):61. PubMed ID: 22734518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-d-N
    Konishi K; Kusakabe S; Kawaguchi N; Shishido T; Ito N; Harada M; Inoue S; Maeda K; Hall WW; Orba Y; Sawa H; Sasaki M; Sato A
    Antiviral Res; 2024 Sep; 229():105977. PubMed ID: 39089332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inactivation of rabies virus by chemical agents].
    Larghi OP; Savy VL; Nebel AE
    Rev Asoc Argent Microbiol; 1975; 7(3):86-90. PubMed ID: 1234351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomics of cerebrospinal fluid from humans treated for rabies.
    O'Sullivan A; Willoughby RE; Mishchuk D; Alcarraz B; Cabezas-Sanchez C; Condori RE; David D; Encarnacion R; Fatteh N; Fernandez J; Franka R; Hedderwick S; McCaughey C; Ondrush J; Paez-Martinez A; Rupprecht C; Velasco-Villa A; Slupsky CM
    J Proteome Res; 2013 Jan; 12(1):481-90. PubMed ID: 23163834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo inhibition of rabies virus replication by RNA interference.
    Durymanova Ono EA; Iamamoto K; Castilho JG; Carnieli P; de Novaes Oliveira R; Achkar SM; Carrieri ML; Kotait I; Brandão PE
    Braz J Microbiol; 2013; 44(3):879-82. PubMed ID: 24516427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.